Skip to content
DataLookout
Menu

NCT07948473

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets in Healthy Volunteers

StatusCompleted
PhasePhase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Maximum Observed Plasma Concentration (Cmax)
Timeframe: From predose to 48 hours postdose in each treatment period
Area Under the Plasma Concentration-Time curve from 0 to t (AUC0-t)
Timeframe: From predose to 48 hours postdose in each treatment period
Area Under the Plasma Concentration-Time Curve From 0 to Infinity (AUC0- ∞)
Timeframe: From predose to 48 hours postdose in each treatment period

Arms and interventions

Fasted Cohort: T-RExperimental
Fasted Cohort: R-TExperimental
Fed Cohort: T-RExperimental
Fed Cohort: R-TExperimental

Drugs: Metformin hydrochloride extended-release tablets 1g

Sites

1 site in 1 country

  • Clinical Trials Center, The Affiliated Hospital of Guizhou Medical UniversityGuiyang, China